Virtual Reality Training Affects on Motor Functions and Mental Health in Stroke Patients

Virtual Reality Training Affects on Motor Functions and Mental Health in Stroke Patients: a Pilot Study

In our study, we tested the hypothesis of the safe effect applicability of motor training in the immersion high-tech polymodal VR system not only on the parameters of balance, gait, and motor status of the patient, but also on his cognitive functions and mental health in patients with a degree of disability no more than 3 points on a scale Rankin.

Study Overview

Detailed Description

The neurological consequences of stroke cover the motor, sensory, visual, affective, cognitive and speech spheres. 55-75% of stroke survivors suffer from motor impairments, caused, inter alia, by hemiparesis, which substantially reduce the quality of their life. In addition, neurocognitive functions, especially memory, visual-constructive abilities and executive functions, are often affected by stroke. Cognitive impairments appear in 83% patients in at least one cognitive domain, whereas in 50% patients appear in multiple (≥3) domains. These disorders affect the quality of life of patients, their skills of daily activity (the ability to go to the store, prepare food, plan their actions for organizing a daily routine), social adaptation. One of the rehabilitation methods that are comprehensively suitable for the recovering on of stroke consequences is the intervention using virtual reality. The VR method is used for the rehabilitation of stroke patients with various motor and neurocognitive deficits: one-sided spatial ignorance, disorders of attention, memory, mood, visual-spatial functions, and constructive abilities.

In our study, we tested the hypothesis of the applicability of the safe effect of motor training in the immersion high-tech polymodal VR system not only on the parameters of balance, gait, and motor status of the patient, but also on his cognitive functions and mental health in patients with a degree of disability no more than 3 score on a modified Rankin Scale.

Stroke patients participated in the study in Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health in Moscow, Russia. The study was run between October 2019 and July 2020 and was approved by a local ethic committee and followed principles of the Declaration of Helsinki. The patients stayed in a 24-hour hospital and underwent a rehabilitation course. This course included a VR Trainig of 10 sessions of 40 minutes each, which the patients took over two weeks. VR training was conducted on the GRAIL system equipment (Motekforce, Netherlands), consisting of a semi-cylindrical screen, treadmill, 10 infrared cameras (Vicon, UK) and reflective markers, and software providing biofeedback in real time. For complex recovery in VR, exercises stimulate the motor, cognitive and behavioral spheres, including visual-spatial orientation, the process of attention (with one and duai-task), executive functions, lowering the level of anxiety, hand-eye coordination and balance.Training applications were based on the therapeutic goals for every patient, according to postural stability and gait adaptation.

Before and after the end of the training, the patient's condition was assessed, including measurements in motor and daily living activity, measurements in mental health, measurements in Virtual Reality.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Moscow, Russian Federation, 117997
        • Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 79 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

with a stroke, transferred at least 2 weeks ago; with no history of neurological or psychiatric disorders; able to maintain an upright posture and walk without support or with minimal support for at least 30 minutes; with stable hemodynamics;

Exclusion Criteria:

not having epileptic activity; not having serious ophthalmic disorders; less than 24 scores in MoCA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Training Group
Training Group recieved 10 sessions on VR (Grail Motekforce, Netherlands) during two weeks. One session lasted 40 minuties.
The training is aimed at improving the functioning of the motor sphere, including balance, gait, and upper limb function, as well as increasing the level of motivation and reducing the level of anxiety and depression. Game applications were selected based on therapeutic tasks of motor recovery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postural stability test (Grail Motekforce)
Time Frame: Change from baseline at 2 weeks
The subject's ability to remain balanced under four different conditions is evaluated (cm/s).
Change from baseline at 2 weeks
Six-minute walk test (6MWT) (Grail Motekforce)
Time Frame: Change from baseline at 2 weeks
The 6-minute walk test evaluates how much distance a subject can cover in six minutes (m).
Change from baseline at 2 weeks
Beck Depression Inventory
Time Frame: Change from baseline at 2 weeks
Measures the severity of depression (0-63; 30-63 scores indicate severe depression)
Change from baseline at 2 weeks
State-Trait Anxiety Inventory
Time Frame: Change from baseline at 2 weeks
Examines two types of anxiety - state anxiety (anxiety about an event) and trait anxiety (anxiety level as a personal characteristic) with the score range from 20 to 80, where higher scores correspond to greater anxiety
Change from baseline at 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Standing Balance Test
Time Frame: Change from baseline at 2 weeks
Examines the patient's ability to maintain an upright position (0-4, where 0 - can't stand)
Change from baseline at 2 weeks
Berg Balance Scale
Time Frame: Change from baseline at 2 weeks
Relates to evaluation of static and dynamic balance, consists of 14 tasks, ranging from standing up from a sitting position, to standing on one foot
Change from baseline at 2 weeks
Timed Up and Go Test
Time Frame: Change from baseline at 2 weeks
Examines functional mobility and requires a patient to stand up, walk 3 meters, turn, walk back, and sit down; result is obtained in seconds
Change from baseline at 2 weeks
Hauser Ambulation Index
Time Frame: Change from baseline at 2 weeks
Assess mobility by evaluating the time and degree of assistance required to walk a 8-m distance as quickly and safely as possible, with scores that range from 0 (asymptomatic) to 10 (bedridden)
Change from baseline at 2 weeks
Rivermead Activities of Daily Living Scales
Time Frame: Change from baseline at 2 weeks
Assesses self-service and two types of domestic activities, maximum scores (90) indicate independence in daily living activity
Change from baseline at 2 weeks
Functional Independence Measure
Time Frame: Change from baseline at 2 weeks
Examines the functional status of the patient in 18 domains related to cognitive and motor functions up to the maximum in 126 scores (independence in daily life)
Change from baseline at 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marina A Shurupova, Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
  • Principal Investigator: Alina D Aizenshtein, Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
  • Study Chair: Galina Ivanova, Prof., Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
  • Principal Investigator: Nadezhda L Cherepahina, PhD, Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2019

Primary Completion (ACTUAL)

July 27, 2020

Study Completion (ACTUAL)

July 27, 2020

Study Registration Dates

First Submitted

December 18, 2020

First Submitted That Met QC Criteria

December 22, 2020

First Posted (ACTUAL)

December 23, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 23, 2020

Last Update Submitted That Met QC Criteria

December 22, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Training on VR

3
Subscribe